SLN140

N/A

Report date: 2024/03/21 13:27:36
NME

Base Information

Drug NameSLN140
Drug Alias NameSLN140
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionVitamin K-dependent protein S inhibitorsRNA interference
TargetsVitamin K-dependent protein S
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesSilence Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A